Predictive Oncology Inc.

NASDAQ: POAI · Real-Time Price · USD
0.86
-0.01 (-1.15%)
At close: Aug 15, 2025, 3:59 PM
0.86
0.48%
After-hours: Aug 15, 2025, 07:53 PM EDT

Predictive Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.07M 1.35M 1.66M 1.38M 1.71M 1.92M 1.74M 1.77M 1.55M 1.43M 1.51M 1.62M 1.48M 1.45M 1.42M 1.24M 1.41M 1.24M
Cost of Revenue
532.66K 849.8K 1.15M 1.27M 1.17M 1.01M 784.06K 531.21K 541.49K 515.8K 505.11K 487.89K 489.91K 498.71K 487.02K 444.87K 509.91K 452.29K
Gross Profit
519.38K 496.51K 500.98K 108.76K 538.75K 907.51K 957.6K 1.24M 1.01M 914.98K 1M 1.13M 986.41K 956.22K 933.66K 793.11K 895.16K 785.35K
Operating Income
-8.7M -9.91M -11.86M -13.25M -13.67M -14.44M -13.67M -14.59M -15.98M -8.18M -8.13M -12.26M -13.63M -20.07M -20.43M -24.41M -24.53M -25.7M
Interest Income
n/a n/a n/a n/a 47.84K 76.39K 118.62K 118.62K 70.78K 42.23K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.67M -9.85M -11.78M -13.16M -13.62M -14.37M -13.57M -18.01M -19.32M -25.79M -25.74M -26.24M -27.62M -19.8M -20.32M -23.37M -24.24M -25.24M
Net Income
-7.71M -10.89M -12.66M -13.97M -14.04M -14.78M -14.82M -33.6M -34.42M -47.99M -47.06M -32.56M -34.01M -19.1M -19.66M -23.37M -24.24M -25.24M
Selling & General & Admin
7.59M 7.87M 8.89M 10.17M 11.65M 12.37M 12.22M 12.66M 12.96M 12.45M 12.47M 12.82M 11.43M 11.05M 11.71M 10.01M 10.12M 11.23M
Research & Development
1.05M 546.39K 25.99K 33.46K 54.13K 83.5K 122.31K 292.4K 286.88K 290.91K 320.32K 198.26K 274.14K 290.44K 315.85K 947.43K 1.43M 1.9M
Other Expenses
1.27M 2.16M 3.62M 3.32M 2.67M 1.8M 1.22M 2.03M 2.91M 3.79M 3.8M 2.7M 1.9M 1.04M -55.1K -100.09K -151.51K -206.71K
Operating Expenses
9.9M 10.57M 12.53M 13.52M 14.37M 15.19M 14.46M 15.67M 16.83M 16.23M 16.27M 16.39M 14.79M 14.06M 14.41M 12.51M 12.55M 13.61M
Interest Expense
n/a n/a n/a n/a n/a n/a 835.34K 835.34K 835.34K 7.97M 7.14M 7.14M 7.14M n/a n/a n/a n/a n/a
Selling & Marketing Expenses
716.63K 732.09K 1.47M 1.65M 1.73M 1.88M 1.51M 1.58M 1.58M 1.42M 1.36M 1.24M 1.08M 964.36K 774.53K 513.3K 461.94K 435.17K
Cost & Expenses
7.79M 11.26M 13.52M 14.63M 15.38M 16.2M 15.25M 16.2M 17.37M 16.75M 16.77M 16.87M 15.28M 14.56M 14.89M 12.96M 13.06M 14.06M
Income Tax Expense
-5 -5 -5 n/a n/a 155.6K 990.93K 15.33M 15.26M 22.2M 21.32M 6.32M 9.2M 2.1M 2.15M 13.93M 12.71M 12.71M
Shares Outstanding (Basic)
9.11M 7.15M 5.45M 8.67M 4.66M 4.06M 4.06M 4.64M 4M 3.97M 3.94M 3.9M 3.59M 3.29M 3.2M 3.27M 2.57M 1.77M
Shares Outstanding (Diluted)
9.11M 7.15M 5.45M 6.4M 4.66M 4.06M 4.06M 4.03M 4M 3.97M 3.94M 3.92M 3.59M 3.29M 3.28M 3.27M 2.58M 1.83M
EPS (Basic)
-1.33 -1.78 -2.48 -2.94 -3.26 -3.56 -3.38 -4.53 -4.89 -6.8 -6.96 -7.31 -7.93 -6.04 -7.15 -17.54 -25.01 -31.28
EPS (Diluted)
-1.45 -1.9 -2.6 -3.06 -3.36 -3.66 -3.48 -4.63 -4.89 -6.8 -6.96 -7.37 -7.99 -6.1 -7.28 -17.61 -25.15 -31.42
EBITDA
-7.96M -9.01M -10.96M -12.76M -13.44M -14.03M -13.18M -13.93M -14.74M -14.09M -13.95M -13.9M -12.46M -11.74M -12.11M -10.42M -10.36M -11.68M
EBIT
-6.72M -9.91M -11.86M -13.25M -13.68M -14.29M -13.52M -14.44M -15.82M -15.32M -15.27M -15.26M -13.8M -13.11M -13.47M -11.72M -11.65M -12.82M
Depreciation & Amortization
779.51K 943.67K 940.17K 524.87K 648.06K 664.03K 739.32K 913.67K 1.08M 1.23M 1.31M 1.35M 1.34M 1.34M 1.34M 1.28M 1.27M 1.14M